ASHLEY PRINCE: Open Payments
NPI 1740938646 · DALLAS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,972 in 95 payments from 28 companies in 2025. Trend: 2023 $57 · 2024 $248 · 2025 $1,972
Food & beverage: $1,972
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $413 |
| Amgen Inc. | 4 | $177 |
| ViiV Healthcare Company | 6 | $174 |
| GlaxoSmithKline, LLC. | 7 | $143 |
| PFIZER INC. | 7 | $126 |
| Novo Nordisk Inc | 6 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $97 |
| Lilly USA, LLC | 5 | $89 |
| Exact Sciences Corporation | 4 | $86 |
| Gilead Sciences, Inc. | 4 | $82 |
Products named: VRAYLAR, QULIPTA, CABENUVA, TRELEGY ELLIPTA, Kerendia, UBRELVY, The Cologuard Plus Collection Kit, NURTEC ODT.
Industry payments across NC — which companies pay providers there.
